Skip links

Vimizim® (elosulfase alfa)

Full Name Vimizim® (elosulfase alfa)
Drug Vimizim
Manufacturer BioMarin Pharmaceutical Inc.
Route of Administration Intravenous
Site of Care Home or Healthcare Facility
Approved Indication Patients with Mucopolysaccharidosis type IVA (MPS IVA; Morquio A syndrome)
Disease Mucopolysaccharidosis IVA
Therapeutic Area Neurology, Genetics
Enrollment Form Link Vimizim Enrollment Form
Phone Number 800-240-9572
Fax Number 877-220-7581
Product Website